Antithymocyte globulin in renal transplant krecipients. A clinical trial.
D000818:Animals; D000961:Antilymphocyte Serum; D001379:Azathioprine / Q000627:therapeutic use; D001485:Basement Membrane; D001798:Blood Proteins; D002102:Cadaver; D003601:Cytotoxicity Tests, Immunologic; D005998:Glycine; D006084:Graft Rejection; D006386:Hemagglutination Tests; D006460:Hemolysin Proteins; D006736:Horses / Q000276:immunology; D006801:Humans; D007122:Immunoelectrophoresis; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D016030:Kidney Transplantation; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D011446:Prospective Studies; D013601:T-Lymphocytes / Q000276:immunology*; D014184:Transplantation, Homologous; D014461:Ultracentrifugation
D000961:Antilymphocyte Serum; D001798:Blood Proteins; D006460:Hemolysin Proteins; D001379:Azathioprine; D005998:Glycine; D011241:Prednisone